RS and good science

November 12, 1999

A Royal Society working group report of September 1998 on genetically modified foods was incorrectly described as "extolling the potential benefits of the technology" (In the News, THES, November 5). It is an assessment of the benefits and risks of GM technology, as the following quote will show: "The use of genetically modified organisms (GMOs) has the potential to offer real benefits in agricultural practice, food quality, nutrition and health. There are, however, uncertainties about several aspects of GMOs. Continued research, funded in part from public sources with the results made openly available, is essential if these uncertainties are to be properly addressed, the risks understood and the full potential of the new technology made clear. All parties must appreciate the public's legitimate concerns; customer confidence, based on an appreciation of the scientific evidence and the regulatory checks and balances, is central to whether GMOs will contribute to feeding the world's rapidly expanding population."

This was written well before the current furore and exemplifies the society's role of promoting good science.

Incidentally, Peter Lachmann is no longer biological secretary of the Royal Society.

Stephen Cox, Executive secretary, The Royal Society

Please login or register to read this article.

Register to continue

Get a month's unlimited access to THE content online. Just register and complete your career summary.

Registration is free and only takes a moment. Once registered you can read a total of 3 articles each month, plus:

  • Sign up for the editor's highlights
  • Receive World University Rankings news first
  • Get job alerts, shortlist jobs and save job searches
  • Participate in reader discussions and post comments

Have your say

Log in or register to post comments

Most commented

Recent controversy over the future directions of both Stanford and Melbourne university presses have raised questions about the role of in-house publishing arms in a world of commercialisation, impact agendas, alternative facts – and ever-diminishing monograph sales. Anna McKie reports

3 October


Featured jobs